Published online
Injections of contaminated steroids lead to a deadly
outbreak of meningitis. Investigations reveal that a compounding pharmacy
manufactured the steroids under unacceptable conditions. Newspaper reports
document significant gaps in oversight by state and federal agencies, and public
health officials call for stronger controls.
The year is 2002.
According to the San Francisco Chronicle, “the case of
Doc's Pharmacy illustrates how doctors, as well as their patients, are unaware
of the risks inherent in pharmacy compounding.”1 Not long
after, the Kansas City Star reviews a series of
compounding-related injuries and deaths from across the country. A
pharmaceutical industry executive is quoted by the paper as saying, “It is just
a matter of time before somebody makes a grossly contaminated product and scores
of people die. . . . People will then be asking, ‘Why did this happen?"
Subscription required. Continue reading here
No comments:
Post a Comment